Mucin-producing cystic neoplasms of the pancreas account for 1% of all malignant tumors of the pancreas. They include mucinous cystic neoplasms (MCNs) and mucinous ductal ectasia (MDE), also known as intraductal mucin-hypersecreting neoplasms.
Methods
This review focuses on the clinical presentation, the role of diagnostic imaging modalities, and cyst fluid analysis preoperatively in the differentiation between these tumors and other nonneoplastic cysts of the pancreas.
Results
MCNs and MDE evolve from pancreatic duct epithelium, produce an abundance of mucin, and are considered premalignant or malignant. While MCNs affect primarily middle-aged women with lesions occurring predominantly in the body and tail of the pancreas, MDE affects primarily men in the sixth or seventh decade with lesions more often located in the head of the pancreas.
Conclusions
All mucin-producing cystic tumors of both types require surgical resection because they are frankly malignant or premalignant. Survival rates of both tumors are better than those reported for ductal cell carcinomas. Future studies are needed to improve the accuracy of diagnosing these tumors preoperatively.
References
1.
LichtensteinD.R., Carr-LockeD.L.. Mucin-secreting tumors of the pancreas.Gastrointest Endosc Clin N Am.1995; 5: 237–258.
2.
BeckerW.F., WelshR.A., PrattH.S.. Cystadenoma and cyst-adenocarcinoma of the pancreas.Ann Surg.1965; 161: 845–863.
3.
OhhashiK., MurakamiF., TakekoshiT.. Four cases of “mucin-producing” cancer of the pancreas on specific findings of the ampulla of Vater.Prog Dig Endosc.1982; 20: 248.
4.
LongneckerD.S.. Observations on the etiology and pathogenesis of intraductal papillary-mucinous neoplasms of the pancreas.Hepatogastroenterology.1998; 45: 1973–1980. Review.
5.
RiveraJ.A., Fernandez-del CastilloC., PinsM.. Pancreatic mucinous ductal ectasia and intraductal papillary neoplasms: a single malignant clinicopathologic entity.Ann Surg.1997; 225: 637–646.
6.
YamadaM., KozukaS., YamaoK.. Mucin-producing tumor of the pancreas.Cancer.1991; 68: 159–168.
7.
RivensonA., HoffmannD., ProkopczykB.. Induction of lung and exocrine pancreas tumors in F344 rats by tobacco-specific and Areca-derived N-nitrosamines.Cancer Res.1988; 48: 6912–6917.
8.
ItaiY., KokuboT., AtomiY.. Mucin-hypersecreting carcinoma of the pancreas.Radiology.1987; 165: 51–55.
9.
CunninghamJ.T., HawesR.H., PayneK.M.. Clinical presentation and ERCP findings in patients with suspected intraductal papillary mucinous tumors (IPMTs).Am J Gastroenterol.1999; 94: A2627.
10.
SeoD.W., KimM.H., LeeS.K.. The value of pancreatoscopy in patients with mucinous ductal ectasia.Endoscopy.1997; 29: 315–318.
11.
CellierC., CuillerierE., PalazzoL.. Intraductal papillary and mucinous tumors of the pancreas: accuracy of preoperative computed tomography, endoscopic retrograde pancreatography and endoscopic ultrasonography, and long-term outcome in a large surgical series.Gastrointest Endosc.1998; 47: 42–49.
12.
ShyrY.M., SuC.H., TsayS.H.. Mucin-producing neoplasms of the pancreas. Intraductal papillary and mucinous cystic neoplasms.Ann Surg.1996; 223: 141–146.
13.
LoftusEVJr, Olivares-PakzadB.A., BattsK.P.. Intraductal papillary-mucinous tumors of the pancreas: clinicopathologic features, outcome, and nomenclature: members of the Pancreas Clinic, and Pancreatic Surgeons of Mayo Clinic.Gastroenterology.1996; 110: 1909–1918.
14.
KoitoK., NamienoT., IchimuraT.. Mucin-producing pancreatic tumors: comparison of MR cholangiopancreatography with endoscopic retrograde cholangiopancreatography.Radiology.1998; 208: 231–237.
15.
YamaguchiK., OgawaY., ChijiiwaK.. Mucin-hypersecreting tumors of the pancreas: assessing the grade of malignancy pre-operatively.Am J Surg.1996; 171: 427–431.
16.
InuiK., NakazawaS., YoshinoJ.. Endoluminal ultrasonography for pancreatic diseases.Gastroenterol Clin North Am.1999; 28: 771–781.
17.
Fernandez-del CastilloC., WarshawA.L.. Cystic tumors of the pancreas.Surg Clin North Am.1995; 75: 1001–1016.
18.
WarshawA.L., ComptonC.C., LewandrowskiK.. Cystic tumors of the pancreas: new clinical, radiologic, and pathologic observations in 67 patients.Ann Surg.1990; 212: 432–445.
19.
JohnsonC.D., StephensD.H., CharboneauJ.W.. Cystic pancreatic tumors: CT and sonographic assessment.A J R Am J Roentgenol.1988; 151: 1133–1138.
20.
CentenoB.A., WarshawA.L., Mayo-SmithW.. Cytologic diagnosis of pancreatic cystic lesions: a prospective study of 28 percutaneous aspirates.Acta Cytol.1997; 41: 972–980.
21.
LewandrowskiK.B., WarshawA.L., ComptonC.C.. Variability in cyst fluid carcinoembryonic antigen level, fluid viscosity, amylase content, and cytologic findings among multiple loculi of a pancreatic mucinous cystic neoplasm.Am J Clin Pathol.1993; 100: 425–427.
22.
RubinD., WarshawA.L., SouthernJ.F.. Expression of CA 15.3 protein in the cyst contents distinguishes benign from malignant pancreatic mucinous cystic neoplasms.Surgery.1994; 115: 52–55.
23.
KoitoK., NamienoT., NagakawaT.. Solitary cystic tumor of the pancreas: EUS-pathologic correlation.Gastrointest Endosc.1997; 45: 268–276.
24.
IkedaM., SatoT., OchiaiM.. Ultrasonographic follow-up study of small pancreatic cysts of unknown etiology.Bildgebung.1993; 60: 209–214.
25.
SugiyamaM., AtomiY., KurodaA.. Two types of mucin-producing cystic tumors of the pancreas: diagnosis and treatment.Surgery.1997; 122: 617–625.
26.
MalleryS., QuirkD., LewandrowskiK.. EUS-guided FNA with cyst fluid analysis in pancreatic cystic lesions.Gastrointest Endosc.1998; 47: A149.
27.
WiersemaM., VilmannP., GiovanniniM.. Prospective multicenter evaluation of EUS-guided fine needle aspiration biopsy (FNA): diagnostic accuracy and complication assessment.Gastrointest Endosc.1996; 43: 432.
28.
HodgkinsonD.J., ReMineW.H., WeilandL.H.. A clinicopathologic study of 21 cases of pancreatic cystadenocarcinoma.Ann Surg.1978; 188: 679–684.
29.
DelcoreR., ThomasJ.H., ForsterJ.. Characteristics of cystic neoplasms of the pancreas and results of aggressive surgical treatment.Am J Surg.1992; 164: 437–442.
